</s><s><s><s> human papillomavirus ( hpv ) vaccine is recommended for adolescents at age 11 or 12 years ; vaccination may be given starting at age 9 years. 
 the minimum intervals are 4 weeks between the first and second doses, 12 weeks after the second and third doses, and 5 months after the first dose of the most recent dose. in 2016, the advisory committee on immunization practices ( a cip ) recommends routine vaccination for adolescents aged 9 through 14 years, with vaccination for females through age 26 years and for males through age 21 years ; males ages 22 through 26 years may be vaccinated. 
 a cIP recommends routine HPV vaccination for children aged <15 years with asplenia, asthma, chronic granulomatous disease, chronic liver and liver diseases, chronic lung and chronic renal disease, central nervous system anatomic barrier defects ( e.g., cochlear implant ), complement deficiency, diabetes, heart disease, or sickle cell disease. </s>